RWM
EW icon

RMG Wealth Management’s Edwards Lifesciences EW Stock Holding History

RMG Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.4K Buy
+342
New +$28.2K ﹤0.01% 211
2025
Q4 		– Sell
-300
Closed -$23.4K – 429
2025
Q3 		$23.4K Hold
300
– – ﹤0.01% 184
2025
Q2 		$23.1K Buy
+300
New +$22.4K ﹤0.01% 184

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

RMG Wealth Management's EW Position: Q1 2026 in Review

RMG Wealth Management opened a new position in Edwards Lifesciences (EW) in Q1 2026: 342 shares worth $26.4K. The stake represents ﹤0.01% of the portfolio and ranks #211 among its holdings. This is a return to the name: RMG Wealth Management previously reported a position in EW as recently as Q3 2025.

RMG Wealth Management first reported a position in EW in Q2 2025 and has held it in 3 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • RMG Wealth Management held 342 shares of Edwards Lifesciences worth $26.4K as of Q1 2026.
  • Edwards Lifesciences was a new RMG Wealth Management position in Q1 2026.
  • Edwards Lifesciences made up ﹤0.01% of RMG Wealth Management's portfolio in Q1 2026, its #211 holding.
  • RMG Wealth Management first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 3 quarters since.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on RMG Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.